HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

DLBS 1033

a protein extract that has both thrombolytic and antithrombotic activities; isolated from the earthworm Lumbricus rubellus

Also Known As:

DLBS-1033; DLBS1033

Networked: 3 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Tissue Extracts: 672
  - DLBS 1033: 3

Experts

1.	Tjandrawinata, Raymond R: 2 articles (01/2021 - 01/2011)
2.	Pinzon, Rizaldy Taslim: 1 article (01/2021)
3.	Veronica, Vanessa: 1 article (01/2021)
4.	Wijaya, Vincent Ongko: 1 article (01/2021)
5.	Susanto, L W: 1 article (06/2016)
6.	Tjandrawinata, R R: 1 article (06/2016)
7.	Yunaidi, D A: 1 article (06/2016)
8.	Suhartono, Maggy T: 1 article (01/2011)
9.	Sunardi, Febrina: 1 article (01/2011)
10.	Trisina, Jessica: 1 article (01/2011)

Related Diseases

1.	Ischemic Stroke 01/01/2021 - "DLBS1033 in addition to the standard care was more effective in improving functional status compared to standard care alone in acute ischemic stroke patients with a similar safety profile." 01/01/2021 - "This study is aimed at measuring the benefit of DLBS1033 in acute ischemic stroke management. " 01/01/2021 - "Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial." 01/01/2021 - "DLBS1033 is a protein fraction extracted from the earthworm Lumbricus rubellus that has shown fibrinolytic and fibrinogenolytic activities, reduces blood viscosity, and inhibits platelet aggregation that it can be considered an add-on therapy and potential medical breakthrough in acute ischemic stroke management. "
2.	Purpura 06/01/2016 - "There were no hemorrhagic symptoms (petechiae, epistaxis, hematoma) and allergic reactions encountered by study subjects during the treatment with DLBS1033 and Placebo. "
3.	Hypersensitivity (Allergy) 06/01/2016 - "There were no hemorrhagic symptoms (petechiae, epistaxis, hematoma) and allergic reactions encountered by study subjects during the treatment with DLBS1033 and Placebo. "
4.	Hematoma 06/01/2016 - "There were no hemorrhagic symptoms (petechiae, epistaxis, hematoma) and allergic reactions encountered by study subjects during the treatment with DLBS1033 and Placebo. "
5.	Epistaxis (Nosebleed) 06/01/2016 - "There were no hemorrhagic symptoms (petechiae, epistaxis, hematoma) and allergic reactions encountered by study subjects during the treatment with DLBS1033 and Placebo. "

Related Drugs and Biologics

1.	Proteins (Proteins, Gene)

Related Therapies and Procedures

1.	Therapeutics